PD, PK, Efficacy and Safety of Balugrastim in Pediatric Patients With Solid Tumors
Study Title
- Pharmacodynamics, Pharmacokinetics, Efficacy and Safety of Balugrastim in Pediatric Patients With Solid Tumors
Teva Identifier
- NEUGR-005
ClinicalTrials.gov Identifier
- NCT01940601
Study Status
- Withdrawn
Trial Condition(s)
- Solid Tumors
Interventions
- Drug: Balugrastim | Drug: Filgrastim
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female, Male
Age Range
- 2 Years to 17 Years
Trial Duration
- 09/01/2014 - 12/01/2015
Phase
- Phase 2
Study Type
Interventional
